Bausch + Lomb announces recall of intraocular lenses on enVista platform

Bausch + Lomb (BLCO) announced a voluntary recall of intraocular lenses on its enVista platform. This action was taken out of an abundance of caution after the company received reports of complications, the cause of which could not immediately be explained. The recall is in response to an increased number of reports of toxic anterior segment syndrome in conjunction with implantation of enVista Aspire, enVista Envy and certain enVista monofocal IOLs. TASS, a potential complication in any cataract surgery, is an inflammatory reaction inside the eye that can have a variety of causes. When it occurs, this complication typically appears 12 – 48 hours after eye surgery. All enVista TASS cases reported to Bausch + Lomb responded quickly to treatment, and none have required removal of the lens.